Review: Troponin has prognostic value in CKD without ACS

Review: troponin has prognostic value in CKD without ACS

(HealthDay)—For patients with chronic kidney disease (CKD) without suspected acute coronary syndrome (ACS), troponin levels may have prognostic and diagnostic value, according to two reviews published online Aug. 12 in the Annals of Internal Medicine.

Erin D. Michos, M.D., M.H.S., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues conducted a of 98 observational studies to examine the prognostic value of troponin for patients with CKD without ACS. The researchers found that, among patients receiving dialysis, elevated correlated with all-cause and cardiovascular mortality. After adjustment for age and coronary artery disease or a risk equivalent, the pooled hazard ratios for all-cause and were 3.0 and 3.3, respectively, for elevated troponin T and 2.7 and 4.2, respectively, for elevated troponin I.

Sylvie R. Stacy, M.D., M.P.H., from the Johns Hopkins University Bloomberg School of Public Health in Baltimore, and colleagues conducted a systematic review involving 23 studies to assess the utility of troponin in ACS diagnosis in patients with CKD with suspected ACS. The researchers found that, for ACS diagnosis, the sensitivity and specificity of troponin T ranged from 71 to 100 percent and from 31 to 86 percent, respectively. For troponin I, the sensitivity and specificity ranged from 43 to 94 percent and from 48 to 100 percent, respectively. Elevated troponin I or troponin T levels correlated with increased risk of short-term death and cardiac events.

"Researchers should continue to try to determine optimal cut points for troponin levels in various patient populations and test management strategies based on these levels," write the authors of an accompanying editorial.

More information: Abstract - Michos
Full Text
Abstract - Stacy
Full Text
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Elevated glucose associated with undetected heart damage

Feb 02, 2012

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that hyperglycemia (high blood sugar) injures the heart, even in patients without a history of heart disease or diabetes. Researchers ...

Recommended for you

Post-PCI bleeding rates vary widely across hospitals

16 hours ago

(HealthDay)—Patient case-mix and procedural factors may contribute to wide variation in the hospital rates of bleeding after percutaneous coronary intervention (PCI), according to research published online ...

Most seniors eligible for statin Rx under new guidelines

Nov 25, 2014

(HealthDay)—Most older Americans qualify for treatment with statins under new guidelines for the treatment of blood cholesterol released late last year by the American College of Cardiology and the American ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.